Medytox 2026 Q1 Preliminary Results: Operating Profit Turns to Black, Net Income Surges 135.7%
-
Sales 60,688 million KRW, down 5.1% YoY
-
Operating profit 7,372 million KRW, turned to black from previous quarter, up 34.6% YoY
-
Net income 7,879 million KRW, up 135.7% YoY
-
Controlling interest net income 7,796 million KRW, up 104.9% YoY
-
Preliminary results, subject to change after external audit review
KOSDAQ Filing Information
-
Filing: Consolidated Financial Statements Basis Operating (Provisional) Results (Fair Disclosure)
-
Company: Medy-Tox (086900)
-
Submission: Medy-Tox Inc.
-
Receipt: 05-12-2026
-
Under KRX KOSDAQ Market Division